Chemical and geometric representation fidelity improves drug--target affinity prediction
Quick summary
arXiv:2609.13230v1 Announce Type: cross Abstract: Predicting drug--target binding affinity (DTA) requires models to distinguish subtle chemical and structural determinants underlying molecular recognition. Although recent approaches increasingly incorporate richer drug and protein information, such information may be compressed, homogenized or discretized during representation construction, causing affinity-relevant distinctions to be lost before interaction modelling. We hypothesized that this representation-stage information loss constitutes an upstream bottleneck that cannot be reliably ove
Key takeaways
- arXiv:2609.13230v1 Announce Type: cross Abstract: Predicting drug--target binding affinity (DTA) requires models to distinguish subtle chemical and structural determinants underlying molecular recognition.
- Although recent approaches increasingly incorporate richer drug and protein information, such information may be compressed, homogenized or discretized during representation construction, causing affinity-relevant distinctions to be lost before interaction modelling.
- We hypothesized that this representation-stage information loss constitutes an upstream bottleneck that cannot be reliably ove
Why it matters
The importance of “Chemical and geometric representation fidelity improves drug--target affinity prediction” will be measured by what changes in practice. User behavior, access conditions, verifiable performance and responsible-use outcomes are the signals worth following.
Member comments